Cancer Screening, Surrogates of Survival, and the Soma.

Thumbnail
View / Open Files
Authors
DeGregori, James
  Pharoah, Paul
Sasieni, Peter
Swanton, Charles
Publication Date
2020-10-12
Journal Title
Cancer Cell
ISSN
1535-6108
Publisher
Cell Press
Volume
38
Issue
4
Pages
433-437
Language
eng
Type
Article
This Version
AM
Metadata
Show full item record
Citation
DeGregori, J., Pharoah, P., Sasieni, P., & Swanton, C. (2020). Cancer Screening, Surrogates of Survival, and the Soma.. Cancer Cell, 38 (4), 433-437. https://doi.org/10.1016/j.ccell.2020.09.003
Abstract
Screening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit.
Embargo Lift Date
2021-09-17
Identifiers
External DOI: https://doi.org/10.1016/j.ccell.2020.09.003
This record's URL: https://www.repository.cam.ac.uk/handle/1810/315140

Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-nd/4.0/

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International